CannPal’s Dr Margaret Curtis presented at the 2019 AVA (Australian Veterinary Association) Innovation, Research and Development Symposium on Sunday, 5th May 2019. She presented the company’s Phase I research results for CPAT-01, in development for pain & inflammation control in dogs. The results will be published in the Australian Veterinary Journal.
Dr Curtis commented: “The Innovation Symposium was a fantastic opportunity to showcase the breadth and depth of CannPal’s research to the veterinary fraternity in Australia.”
Invetus partnered with CannPal on this important research, and a former staff member is recognised as a co-author on the paper - Dr Christie Budd, previously Research Leader at Wongaburra Research Centre. Medicinal cannabis products are cutting edge therapies, with both veterinary and human health applications, and the pharma industry has shown a lot of interest.
To read the ASX press release from CannPal on Phase I research results for CPAT-01, please click here.
We are delighted the results met CannPal’s expectations and hope to continue our research partnership.